DILIC
NVAX icon

Dai-ichi Life Insurance Company’s Novavax NVAX Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,727
Closed -$533K – 533
2021
Q4 		$533K Buy
3,727
+60
+2% +$10.3K 0.01% 461
2021
Q3 		$760K Buy
+3,667
New +$808K 0.01% 446

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dai-ichi Life Insurance Company's NVAX Position: Q1 2022 in Review

Dai-ichi Life Insurance Company sold out of Novavax (NVAX) in Q1 2022, closing a stake of 3,727 shares — an estimated $533K sold.

Dai-ichi Life Insurance Company first reported a position in NVAX in Q3 2021 and held it in 2 quarters. The position peaked at $760K in Q3 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Dai-ichi Life Insurance Company reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 3,727 Novavax shares in Q1 2022, an estimated $533K.
  • Dai-ichi Life Insurance Company first reported a position in Novavax in Q3 2021 and held it in 2 quarters.
  • Dai-ichi Life Insurance Company's Novavax position peaked at $760K in Q3 2021.
  • 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2022, filed 13 May 2022.